Modafinil vs Methylphenidate
The table compares the compounds’ key data from their entry pages. Open each compound’s full entry for details. Educational content, not medical advice.
Modafinil | Methylphenidate | |
|---|---|---|
| What it is | Prescription wakefulness-promoting medicine for narcolepsy, shift-work sleep disorder and sleepiness that remains in sleep apnea. | Prescription stimulant for ADHD; tightly controlled because it can be misused and cause dependence. |
| ATC codeATC codeThe WHO Anatomical Therapeutic Chemical code that classifies drugs by organ system and mechanism. | N06BA07 | N06BA04 |
| Prescription | Prescription only (Rx), DEA Schedule IV (USA) | Prescription only (Rx), narcotic Rx; DEA Schedule II |
| MechanismMechanism of actionThe molecular pathway by which a compound acts in the body (e.g. which receptor or enzyme it binds). | DAT inhibitor + histamine/orexin activation | DAT/NET reuptake inhibitor CNS stimulant (dopamine + norepinephrine) |
| Half-lifeHalf-lifeThe time for the compound’s plasma concentration to fall by half; indicates how fast it clears and how often it is dosed. | 12-15 h | About 3.5 hours (immediate-release form); extended-release effect lasts 10–12 hours |
| OnsetOnsetThe time from dosing until a measurable effect appears. | 30-60 min, peak 2-4 h | Immediate-release 30–45 min, peak effect 1–3 hours; extended-release 1–2 hours |
| Full entry | Open → | Open → |
Modafinil or methylphenidate: what is the difference?
Both are prescription medicines and both block the dopamine transporter, but they are used for different purposes. Modafinil keeps you awake, but according to its entry without revving up the whole nervous system the way classic stimulants do: besides dopamine it activates the histamine and orexin systems that regulate wakefulness; methylphenidate is a stimulant that blocks the reuptake of noradrenaline as well as dopamine. Modafinil is approved for narcolepsy, sleep problems caused by shift work and leftover sleepiness in sleep apnea, while methylphenidate is the usual first-choice treatment for ADHD and is also used in narcolepsy. Their regulation differs too: in the United States modafinil is in Schedule IV, with low abuse potential, and methylphenidate in Schedule II, and in Hungary methylphenidate can only be prescribed on a narcotics prescription.

